Galmed To Design Phase III NASH Trial With FDA After Strong Aramchol Data

 
• By Sten Stovall
Obese
Talks To Follow 'Positive Top-Line Data' From Phase IIb ARREST study • Source: Shutterstock

More from Clinical Trials

More from R&D